← Leaderboards
Barry W Rovner
Thomas Jefferson University
$21,883,735
Attributed
$22,149,932
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$22,149,932 · 9
By mechanism
R01$13,726,275 · 5
U01$7,550,269 · 2
R34$474,092 · 1
R25$399,296 · 1
Top collaborators
- Hakeem O Lawal1 shared
- Susan Mockus Parks1 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Harris Goldstein$29,313,609
- Susan Mockus Parks$555,668
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventQuality Of LifeMediatingHome EnvironmentEfficacy TestingPrimary OutcomeCostInnovationTreatment EffectDiabetes MellitusRecruitment ActivityMedicalCaringAgingCognitiveAfrican AmericanRandomizedParticipantHigh RiskElderlyMild Cognitive ImpairmentMental DepressionCognitionBase
Grant awards (35)
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial$558,912
R01 · FY2024 · AG · contact PI
Inspiring Undergraduate Student Training in Alzheimer's Research$399,296
R25 · FY2024 · AG · contact PI
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial$757,048
R01 · FY2023 · AG · contact PI
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial$752,288
R01 · FY2022 · AG · contact PI
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial$766,245
R01 · FY2021 · AG · contact PI
Reducing Emergency Diabetes Care for Older African Americans$665,586
R01 · FY2021 · DK · contact PI
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial$779,451
R01 · FY2020 · AG · contact PI
Reducing Emergency Diabetes Care for Older African Americans$685,252
R01 · FY2020 · DK · contact PI
Reducing Emergency Diabetes Care for Older African Americans$694,986
R01 · FY2019 · DK · contact PI
Reducing Emergency Diabetes Care for Older African Americans$700,857
R01 · FY2018 · DK · contact PI
Improving Medication Adherence in Older African Americans with Diabetes$534,001
R01 · FY2017 · DK · contact PI
Improving Medication Adherence in Older African Americans with Diabetes$630,120
R01 · FY2016 · DK · contact PI
Improving Medication Adherence in Older African Americans with Diabetes$613,427
R01 · FY2015 · DK · contact PI
Collaborative Care for Depression and Diabetic Retinopathy in African Americans$228,189
R34 · FY2015 · EY · contact PI
Improving Medication Adherence in Older African Americans with Diabetes$655,877
R01 · FY2014 · DK · contact PI
Preventing Cognitive Decline in African Americans with Mild Cognitive Impairment.$484,717
R01 · FY2014 · AG · contact PI
Collaborative Care for Depression and Diabetic Retinopathy in African Americans$245,903
R34 · FY2014 · EY · contact PI
Preventing Cognitive Decline in African Americans with Mild Cognitive Impairment.$453,726
R01 · FY2013 · AG · contact PI
Preventing Cognitive Decline in African Americans with Mild Cognitive Impairment.$507,350
R01 · FY2012 · AG · contact PI
Low Vision Depression Prevention Trial for Age Related Macular Degeneration$609,888
U01 · FY2011 · EY · contact PI
Preventing Cognitive Decline in African Americans with Mild Cognitive Impairment.$507,595
R01 · FY2011 · AG · contact PI
Low Vision Depression Prevention Trial for Age Related Macular Degeneration$936,326
U01 · FY2010 · EY · contact PI
Preventing Cognitive Decline in African Americans with Mild Cognitive Impairment.$620,120
R01 · FY2010 · AG · contact PI
Low Vision Depression Prevention Trial for Age Related Macular Degeneration$1,129,442
U01 · FY2009 · EY · contact PI
Improving Function In Age-Related Macular Degeneration$377,927
U01 · FY2009 · EY · contact PI
Low Vision Depression Prevention Trial for Age Related Macular Degeneration$994,137
U01 · FY2008 · EY · contact PI
Improving Function In Age-Related Macular Degeneration$844,889
U01 · FY2008 · EY · contact PI
Improving Function In Age-Related Macular Degeneration$864,079
U01 · FY2007 · EY · contact PI
Improving Function In Age-Related Macular Degeneration$879,567
U01 · FY2006 · EY · contact PI
Improving Function In Age-Related Macular Degeneration$914,014
U01 · FY2005 · EY
PREVENTING DEPRESSION IN MACULAR DEGENERATION$184,271
R01 · FY2005 · MH
PREVENTING DEPRESSION IN MACULAR DEGENERATION$398,270
R01 · FY2004 · MH
PREVENTING DEPRESSION IN MACULAR DEGENERATION$652,331
R01 · FY2003 · MH
PREVENTING DEPRESSION IN MACULAR DEGENERATION$634,952
R01 · FY2002 · MH
PREVENTING DEPRESSION IN MACULAR DEGENERATION$488,893
R01 · FY2001 · MH